Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

PSNL

Personalis (PSNL)

Personalis Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PSNL
DateTimeSourceHeadlineSymbolCompany
08/30/20244:43PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:PSNLPersonalis Inc
08/22/20244:01PMBusiness WirePersonalis to Participate at Upcoming Investor ConferencesNASDAQ:PSNLPersonalis Inc
08/20/20244:27PMEdgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:PSNLPersonalis Inc
08/20/20244:17PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PSNLPersonalis Inc
08/19/20244:05PMBusiness WirePersonalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:PSNLPersonalis Inc
08/16/20249:25AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PSNLPersonalis Inc
08/16/20248:30AMBusiness WirePersonalis and Tempus Announce Expanded CollaborationNASDAQ:PSNLPersonalis Inc
08/07/20244:35PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PSNLPersonalis Inc
08/07/20244:01PMBusiness WirePersonalis Reports Second Quarter 2024 Financial ResultsNASDAQ:PSNLPersonalis Inc
08/07/20244:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PSNLPersonalis Inc
08/06/20244:05PMGlobeNewswire Inc.Myriad Genetics Reports Strong Second Quarter 2024 Financial Results, including 15% Revenue Growth Year-Over-Year; Raises 2024 Financial Guidance and Long-Term Revenue Growth Target to 12%NASDAQ:PSNLPersonalis Inc
08/01/20245:16PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PSNLPersonalis Inc
08/01/20245:16PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PSNLPersonalis Inc
07/31/20244:01PMBusiness WirePersonalis to Participate at the 9th Annual Needham Virtual MedTech & Diagnostics 1x1 ConferenceNASDAQ:PSNLPersonalis Inc
07/24/20244:01PMBusiness WirePersonalis to Announce Second Quarter 2024 Financial ResultsNASDAQ:PSNLPersonalis Inc
07/11/20249:00AMGlobeNewswire Inc.Myriad Genetics and Personalis Cross-License Foundational MRD Intellectual Property to Broaden Patient Access to TestingNASDAQ:PSNLPersonalis Inc
06/18/20244:01PMBusiness WirePersonalis to Participate at the TD Cowen 3rd Annual Tools / Dx Revolution ConferenceNASDAQ:PSNLPersonalis Inc
06/13/20248:00AMBusiness WirePersonalis Provides Dial-in and Updated Date for ASCO Highlights Conference CallNASDAQ:PSNLPersonalis Inc
06/04/20244:05PMBusiness WireASCO Data Highlights NeXT Personal® Ultra-sensitive MRD Performance in Early-stage Breast Cancer Recurrence Detection and Immunotherapy MonitoringNASDAQ:PSNLPersonalis Inc
05/31/20249:05AMBusiness WirePersonalis Announces Start of Cancer MRD Testing Commercialization Collaboration with TempusNASDAQ:PSNLPersonalis Inc
05/22/20249:05AMBusiness WirePersonalis Announces Podium Presentations and Abstracts Accepted at ASCO 2024NASDAQ:PSNLPersonalis Inc
05/21/20249:14PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PSNLPersonalis Inc
05/21/20249:11PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PSNLPersonalis Inc
05/21/20244:12PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PSNLPersonalis Inc
05/17/20244:05PMBusiness WirePersonalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:PSNLPersonalis Inc
05/08/20244:01PMBusiness WirePersonalis Reports First Quarter 2024 Financial ResultsNASDAQ:PSNLPersonalis Inc
05/08/20244:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PSNLPersonalis Inc
04/24/20244:01PMBusiness WirePersonalis to Announce First Quarter 2024 Financial ResultsNASDAQ:PSNLPersonalis Inc
03/28/20244:01PMBusiness WirePersonalis to Present at the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:PSNLPersonalis Inc
03/28/20249:00AMBusiness WireData Showcasing NeXT Personal MRD Test to be Presented at the 2024 American Association for Cancer Research (AACR) Annual MeetingNASDAQ:PSNLPersonalis Inc
 Showing the most relevant articles for your search:NASDAQ:PSNL

Your Recent History

Delayed Upgrade Clock